Camarda Financial Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-11
| Closed | -$1K | – | 224 |
|
|
2019
Q2 | $1K | Sell |
11
-387
| -97% | -$35.2K | ﹤0.01% | 414 |
|
|
2019
Q1 | $21K | Buy |
+398
| New | +$21K | 0.04% | 134 |
|
|
2018
Q1 | – | Sell |
-1,600
| Closed | -$71K | – | 179 |
|
|
2017
Q4 | $71K | Hold |
1,600
| – | – | 0.09% | 101 |
|
|
2017
Q3 | $81K | Hold |
1,600
| – | – | 0.09% | 100 |
|
|
2017
Q2 | $86K | Hold |
1,600
| – | – | 0.09% | 98 |
|
|
2017
Q1 | $84K | Hold |
1,600
| – | – | 0.08% | 100 |
|
|
2016
Q4 | $77K | Sell |
1,600
-208
| -12% | -$10K | 0.05% | 110 |
|
|
2016
Q3 | $97K | Hold |
1,808
| – | – | 0.06% | 104 |
|
|
2016
Q2 | $98K | Buy |
1,808
+208
| +13% | +$11.3K | 0.06% | 110 |
|
|
2016
Q1 | $81K | Hold |
1,600
| – | – | 0.05% | 136 |
|
|
2015
Q4 | $81K | Hold |
1,600
| – | – | 0.05% | 150 |
|
|
2015
Q3 | $77K | Hold |
1,600
| – | – | 0.05% | 106 |
|
|
2015
Q2 | $83K | Sell |
1,600
-184
| -10% | -$9.55K | 0.05% | 106 |
|
|
2015
Q1 | $103K | Hold |
1,784
| – | – | 0.06% | 103 |
|
|
2014
Q4 | $95K | Hold |
1,784
| – | – | 0.06% | 102 |
|
|
2014
Q3 | $103K | Buy |
1,784
+184
| +12% | +$10.6K | 0.07% | 93 |
|
|
2014
Q2 | $107K | Sell |
1,600
-400
| -20% | -$26.8K | 0.07% | 96 |
|
|
2014
Q1 | $134K | Buy |
+2,000
| New | +$134K | 0.1% | 85 |
|